This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Geneseeq Technology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Detection by Hua Bao
Introduction
Hua Bao is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of cancer detection through his innovative research and development. His work focuses on the application of gene markers for early detection of multiple cancers, which has the potential to revolutionize cancer diagnostics.
Latest Patents
Hua Bao holds a patent for the "Application of gene markers in multi-cancer early detection, method for constructing early detection model, and detection device." This patent involves conducting low-coverage whole-genome sequencing on cell-free DNAs (cfDNAs) from plasma samples. The process analyzes six differential features of cfDNA fragments for each type of cancer. By utilizing advanced modeling techniques, including convolutional neural networks and generalized linear models, his invention allows for the early detection of various cancers at a low sequencing depth.
Career Highlights
Hua Bao is associated with Geneseeq Technology Inc., where he continues to push the boundaries of cancer research. His innovative approach combines cutting-edge technology with practical applications in the medical field. His work has garnered attention for its potential to improve early cancer detection rates, ultimately leading to better patient outcomes.
Collaborations
Hua Bao collaborates with talented individuals such as Yang Shao and Min Wu. Their combined expertise enhances the research and development efforts at Geneseeq Technology Inc., fostering an environment of innovation and discovery.
Conclusion
Hua Bao's contributions to cancer detection through his innovative patent demonstrate the importance of research in improving healthcare outcomes. His work exemplifies the potential of technology to transform the way we approach cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile